Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $208.2700 (-0.75%) ($208.2700 - $208.2700) on Tue. Sep. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.3% (three month average) | RSI | 58 | Latest Price | $208.2700(-0.75%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 0.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(39%) VYM(33%) VFMO(32%) XLP(31%) XLF(28%) | Factors Impacting UTHR price | UTHR will decline at least -1.15% in a week (0% probabilities). VIXM(-24%) VXX(-17%) UUP(-13%) IGOV(-12%) BND(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.15% (StdDev 2.3%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $208.5 | 5 Day Moving Average | $209.97(-0.81%) | 10 Day Moving Average | $210.79(-1.2%) | 20 Day Moving Average | $208.5(-0.11%) | To recent high | -3.3% | To recent low | 19.3% | Market Cap | $9.238b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |